JEAN NELSON: Open Payments
NPI 1205835337 · SCOTTSDALE, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$58,844 in 257 payments from 23 companies in 2025. Trend: 2023 $22,427 · 2024 $35,166 · 2025 $58,844
Speaker / faculty: $24,572Consulting: $21,645Travel & lodging: $8,036Food & beverage: $4,523Education: $68
| Company | Payments | Amount |
|---|---|---|
| Pharming Healthcare, Inc. | 58 | $21,267 |
| Takeda Pharmaceuticals U.S.A., Inc. | 45 | $12,132 |
| AstraZeneca Pharmaceuticals LP | 23 | $11,062 |
| Regeneron Healthcare Solutions, Inc. | 23 | $5,777 |
| Ionis Pharmaceuticals, Inc. | 10 | $3,630 |
| BioCryst US Sales Co., LLC | 8 | $1,862 |
| BioCryst Pharmaceuticals, Inc. | 1 | $1,307 |
| GlaxoSmithKline, LLC. | 32 | $497 |
| CSL Behring | 10 | $262 |
| Genentech USA, Inc. | 2 | $176 |
Products named: RUCONEST, FASENRA, CUVITRU, DUPIXENT, HYQVIA, DAWNZERA, TEZSPIRE, ORLADEYO.
Industry payments across AZ — which companies pay providers there.
